REG - Oxford Biomedica PLC - PDMR Shareholding <Origin Href="QuoteRef">OXB.L</Origin>

Oxford BioMedicaAnnouncement

14/07/2017 15:30

RNS Number : 1574L
Oxford Biomedica PLC
14 July 2017
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
1
Issuer
Oxford BioMedica PLC
2
Reason for notification
Notification relates to DTR 3.1.2R
3
Name of PDMR
Martin Diggle
4
Connected person
Notification relates to following connected persons:
Vulpes Testudo Fund
5
Notification in respect of
Notification in respect of holdings of persons in 4 above
6
Description of shares
Oxford BioMedica PLC ordinary shares of 1p each
7
Name of registered shareholders and number of shares
Vulpes Life Sciences Fund - 549,932,000 shares
Vulpes Testudo Fund - 33,333,333 shares
8
Nature of transaction
Acquisition and Disposal 
9
Number of shares acquired
Vulpes Testudo Fund - 660,000 shares
10
Percentage of issued class acquired
Vulpes Testudo Fund- 0.02%
11
Shares disposed
Vulpes Testudo Fund - 658,899
12
Percentage of issued class disposed
Vulpes Testudo Fund - 0.02%
13/14
Price per share of transactions, and date
Vulpes Testudo Fund 
Sold 658,899 shares @ 0.1003, 13 Jan 2017
Bought 660,000 shares @ 0.089, 13 Jan 2017
15
Total holding following notification and total percentage holding following notification
Vulpes Life Sciences Fund - 549,932,000 shares
17.8%
Vulpes Testudo Fund - 33,334,434 shares
1.1%
16
Date issuer informed
14 July 2017



23
Any additional information
None
24
Contact name and telephone number
T. Watts, Chief Financial Officer
Oxford BioMedica
+44 (0)1865 783000

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHKMGMNFDVGNZM